BCL2 and urinary bladder carcinoma: Our study found that knockdown of SHMT2 promoted apoptosis through upregulation of Bax and cleaved caspase3 expression and downregulation of Bcl-2 level, consistent with the role of SHMT2 on apoptosis in bladder cancer [36].